Back

Relationship between time in systolic target range during 24-hour ambulatory blood pressure monitoring and mortality

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Blood pressure measurement Blood Pressure Measurement ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Lucas Lauder

University Hospital Basel, Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
Guiding hypertension management using different blood pressure monitoring strategies (GYMNs study): comparison of three different blood pressure measurement methods
Doctor C. Lee (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Association between nocturnal hypertension and composite cardiovascular outcomes in the extremely elderly population aged over 80 years
Doctor T. Fujiwara (Shimotsuke, JP)
Abstract Slides Video
Presentation thumbnail
The usefulness of automatic office blood pressure measurement in comparison with 44-hour ambulatory blood pressure monitoring in hemodialyzed patients - preliminary results.
Doctor M. Zaborska-Dworak (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Is blood pressure monitoring using photoplethysmography on a smartwatch a reliable method ?
Professor R. Fenici (Rome, IT) Assistant Professor D. Brisinda (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Predict abnormal nighttime blood pressure feature by home blood pressure feature by using a machine learning approach
Doctor C. Lee (Taipei, TW)
Abstract Slides Video

Access the full session

Session thumbnail
Blood pressure measurement

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Systolic blood pressure time in target range and cardiovascular disease and premature death
thumbnail
Congress Presentation
Systolic blood pressure time in target range and acute kidney injury in patients with hypertension
thumbnail
Congress Presentation
Differential impact of clinic BP target on the prevalence and predictors of the masked uncontrolled hypertension and white-coat uncontrolled hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources